help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernández, J.
Right arrow Articles by Glatstein, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernández, J.
Right arrow Articles by Glatstein, E.
The Oncologist, Vol. 2, No. 4, 235–244, August 1997
© 1997 AlphaMed Press

Classification of Non-Hodgkin’s Lymphoma: A Proposal

José Hernándeza, Jo Ellen Cottey Krueger, Eli Glatsteinb

University of Texas Southwestern Medical Center, Dallas, Texas, USA

Correspondence: Jo Ellen Cottey Krueger, M.D., University of Texas Southwestern Medical Center, 5731 Southwestern Boulevard., Dallas, Texas 75209, USA. Telephone: 214-353-3989; Fax: 214-590-6667.

The pathology community has traditionally classified the non-Hodgkin’s lymphomas (NHL) according to their histogenetic characteristics, an approach that has fostered the proliferation of multiple, often conflicting, lymphoma classification schemes with limited clinical relevance. The scientific acceptance of these histogenetically pure schemes is based on an implicit belief that all that is scientifically sound must adhere to linear dynamic theory; that is, that the elemental components of a system in a linear and direct fashion control the behavior of the whole. Non-linear dynamic theory, however, which has recently acquired acceptance within the scientific community, offers another equally valid approach to the classification of the NHL by acknowledging the inherent indeterminacy of nature. In other words, rather than classifying the NHL according to their cell of origin in the hopes that the elemental unit will predict the clinical outcome, we propose that pathologists accept the premise that nature is inherently unpredictable and define the NHL according to their clinical characteristics, such as natural history and response to therapy. Using these criteria, a proposed classification is discussed containing two major subtypes of lymphomas (indolent and aggressive) which can be further subdivided into five groups: the low-grade, or indolent, group includes the small lymphocytic and the follicular cleaved cell (small, and small, mixed) categories, while the high-grade, or aggressive, group includes the large-cell, the Burkitt’s lymphoma, and the lymphoblastic lymphomas. Each of these groups is discussed in detail, with comparisons to the Revised European American Lymphoma classification to demonstrate clinical relevance. Although it is clear to us that the proposed scheme presented in this manuscript is not the only clinically valid one that can be constructed, it is equally clear that any scheme that is developed—in order to be considered valid—must be guided principally by its clinical relevance.

Key Words. Non-Hodgkin’s lymphoma • Small lymphocytic lymphoma • Follicular cleaved lymphoma • Large cell lymphoma • Burkitt’s lymphoma • Lymphoblastic lymphoma • Linear dynamic theory • Non-linear dynamics







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 1997 by AlphaMed Press.